ARCT vs. CNXC
Compare and contrast key facts about Arcturus Therapeutics Holdings Inc. (ARCT) and Concentrix Corporation (CNXC).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ARCT or CNXC.
Key characteristics
| ARCT | CNXC | |
|---|---|---|
| YTD Return | -13.35% | -37.16% |
| 1Y Return | 0.81% | -28.49% |
| 3Y Return (Ann) | -4.95% | -26.49% |
| Sharpe Ratio | 0.04 | -0.69 |
| Daily Std Dev | 69.25% | 41.08% |
| Max Drawdown | -97.70% | -72.83% |
| Current Drawdown | -84.70% | -69.47% |
Fundamentals
| ARCT | CNXC | |
|---|---|---|
| Market Cap | $734.33M | $3.92B |
| EPS | -$1.12 | $4.78 |
| PE Ratio | 10.30 | 12.42 |
| Revenue (TTM) | $166.80M | $7.88B |
| Gross Profit (TTM) | $62.95M | $2.26B |
| EBITDA (TTM) | -$75.25M | $1.24B |
Correlation
The correlation between ARCT and CNXC is 0.24, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
ARCT vs. CNXC - Performance Comparison
In the year-to-date period, ARCT achieves a -13.35% return, which is significantly higher than CNXC's -37.16% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ARCT vs. CNXC - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Arcturus Therapeutics Holdings Inc. (ARCT) and Concentrix Corporation (CNXC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ARCT vs. CNXC - Dividend Comparison
ARCT has not paid dividends to shareholders, while CNXC's dividend yield for the trailing twelve months is around 1.93%.
| TTM | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
ARCT Arcturus Therapeutics Holdings Inc. | 0.00% | 0.00% | 0.00% | 0.00% |
CNXC Concentrix Corporation | 1.93% | 1.15% | 0.77% | 0.14% |
Drawdowns
ARCT vs. CNXC - Drawdown Comparison
The maximum ARCT drawdown since its inception was -97.70%, which is greater than CNXC's maximum drawdown of -72.83%. Use the drawdown chart below to compare losses from any high point for ARCT and CNXC. For additional features, visit the drawdowns tool.
Volatility
ARCT vs. CNXC - Volatility Comparison
Arcturus Therapeutics Holdings Inc. (ARCT) has a higher volatility of 19.26% compared to Concentrix Corporation (CNXC) at 11.05%. This indicates that ARCT's price experiences larger fluctuations and is considered to be riskier than CNXC based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
ARCT vs. CNXC - Financials Comparison
This section allows you to compare key financial metrics between Arcturus Therapeutics Holdings Inc. and Concentrix Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities